TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
ANL

Adlai Nortye Ltd.

Healthcare · Biotechnology

16.00$ +2.2% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Income Statement

Adlai Nortye Ltd. (ANL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 7.3 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Income Statement ANL
Line item Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 25 Q1 26 Q2 26
– – – 0.0 0.0 2.5 2.5 0.7 0.7 2.5 7.3 7.3
– – – 0.5 0.6 – – – – – – –
– – – -0.5 -0.6 2.5 2.5 0.7 0.7 2.5 7.3 7.3
13 16 16 13 14 15 15 13 13 8.8 7.3 7.3
4.5 3.0 3.0 2.1 3.1 5.0 5.0 2.4 2.4 2.1 2.9 2.9
18 19 19 15 17 20 15 15 15 11 10 10
-18 -19 -19 -15 -17 -20 -18 -15 -15 -8.3 -2.9 -2.9
0.1 – – 0.1 0.2 0.3 – 0.5 0.5 0.4 0.2 0.2
-3.5 -22 -22 -15 -63 -15 -13 -14 -14 -8.6 -2.7 -2.7
14 – – 0.3 -46 0.3 0.3 0.3 – – – –
-3.5 -22 -22 -15 -63 -15 -13 -14 -14 -8.6 -2.7 -2.7
-2.9 -19 -19 -14 -63 -20 -17 -14 -14 -8.0 -2.7 -2.7

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?